Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Itraconazole

Itraconazole

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Itraconazole

65 trials tracked of Itraconazole: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 622 citations.

65Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 3 Phase 3 2 Phase 2 5 Phase 1 52 Other / NA 3
  1. Phase 3 Assessment of Mechanisms of Improved Wound Healing Completed · 622 cited
  2. Phase 4 Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis Completed · 84 cited
  3. Phase 4 An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections Completed
  4. Phase 4 Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules Completed
  5. Phase 3 Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Completed
  6. Phase 2 Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) Completed
Show 44 more trials
  1. Phase 2 PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2) Completed
  2. Phase 2 Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer Completed
  3. Phase 2 Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis Completed
  4. Phase 2 Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas Completed
  5. Phase 1 Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam Completed
  6. Phase 1 Neoadjuvant Itraconazole in Non-small Cell Lung Cancer Completed
  7. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of Zongertinib (BI 1810631) in the Blood Completed
  8. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood Completed
  9. Phase 1 A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants Completed
  10. Phase 1 This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood Completed
  11. Phase 1 A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunteers Completed
  12. Phase 1 Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants Completed
  13. Phase 1 Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels Completed
  14. Phase 1 A Study of LY3484356 in Healthy Female Participants Completed
  15. Phase 1 Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers Completed
  16. Phase 1 Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors Completed
  17. Phase 1 Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects Completed
  18. Phase 1 A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults Completed
  19. Phase 1 Tepotinib Drug-Drug Interaction Study With Itraconazole in Healthy Participants Completed
  20. Phase 1 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects Completed
  21. Phase 1 Interaction of BI 691751 With Itraconazole Completed
  22. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood Completed
  23. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood Completed
  24. Phase 1 A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants Completed
  25. Phase 1 A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood Completed
  26. Phase 1 Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours Completed
  27. Phase 1 A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants Completed
  28. Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole Completed
  29. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the Blood Completed
  30. Phase 1 Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants Completed
  31. Phase 1 A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults Completed
  32. Phase 1 A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer Completed
  33. Phase 1 A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants Completed
  34. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood Completed
  35. Phase 1 A Study of LY2623091 in Healthy Participants Completed
  36. Phase 1 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib Completed
  37. Phase 1 A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers Completed
  38. Phase 1 Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva) Completed
  39. Phase 1 A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease Completed
  40. Phase 1 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood Completed
  41. Phase 1 Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers Completed
  42. Phase 1 Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer Completed
  43. Phase 1 A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood Completed
  44. Phase 1 Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin Completed

Showing the 50 most-cited and recently-updated of 65 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans
Primary Care & Family Medicine Guideline
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans Lab study finds coffee bean fungi often resist common antifungal drugs
This laboratory study evaluated antifungal susceptibility of Aspergillus spp. isolated from coffee beans in Costa Rica. The authors report m…
Laboratory testing of fungi from Costa Rican coffee beans shows many strains resist standard antifungal medications like amphotericin B and …
Frontiers May 20, 2026
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients Antifungal resistance high in diabetic foot ulcers
This systematic review and meta-analysis evaluated antifungal resistance in patients with diabetic foot ulcers.
Many diabetic foot ulcer infections resist common antifungals, especially nystatin and itraconazole.
May 1, 2026